Parallel Advisors’s CERo Therapeutics Warrants CEROW Stock Holding History

Parallel Advisors’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27,500	Closed	-$366	–	3772
2025 Q3	$366	Sell	27,500 -22,500	-45%	-$401	﹤0.01%	3368
2025 Q2	$1.19K	Hold	50,000	–	–	﹤0.01%	3166
2025 Q1	$725	Buy	+50,000	New	+$705	﹤0.01%	3178

Other funds holding CEROW

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Parallel Advisors's CEROW Position: Q4 2025 in Review

Parallel Advisors sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 27,500 shares — an estimated $366 sold.

Parallel Advisors first reported a position in CEROW in Q1 2025 and held it in 3 quarters. The position peaked at $1.19K in Q2 2025. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

Parallel Advisors reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
Parallel Advisors sold 27,500 CERo Therapeutics Warrants shares in Q4 2025, an estimated $366.
Parallel Advisors first reported a position in CERo Therapeutics Warrants in Q1 2025 and held it in 3 quarters.
Parallel Advisors's CERo Therapeutics Warrants position peaked at $1.19K in Q2 2025.
1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Parallel Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.